Department of Otolaryngology, Head and Neck Surgery, Medical University Vienna, Austria.
Department of Otorhinolaryngology, Tertiary Teaching Hospital Rudolfstiftung, Vienna, Austria.
Laryngoscope. 2020 Nov;130(11):E580-E586. doi: 10.1002/lary.28413. Epub 2019 Nov 20.
To evaluate whether elective tracheostomy is justified after tumor resection and bilateral neck dissection (ND) and whether application of tracheostomy scoring systems is reliable for planning of postoperative airway management.
Retrospective cohort study.
We retrospectively assessed airway management in 160 patients with head and neck squamous cell carcinomas. Additionally, we applied and analyzed the 1) Cameron, 2) TRACHY, and 3) CASST tracheostomy scoring systems on the tracheostomy recommendations.
Elective tracheostomies were performed in 51.3% of our patients, particularly in T3 to T4 tumors, cases with free flap reconstruction, and concurrent procedures. Among patients undergoing concurrent procedures, those who received tracheostomy showed significantly longer inpatient stays (27.8 ± 30.0 days vs. 13.3 ± 6.6 days; P < 0.001). Tracheostomy recommendation coincides with the performance of bilateral ND in 28.6% (CASST), 60.0% (Cameron), and 75.0% (TRACHY) of the cases, respectively. By applying corresponding criteria, tracheostomy would be recommended in 2.5% (CASST), 76.9% (Cameron), and 84.4% (TRACHY) of our cases. Bleeding episodes were the most common complication occurring in 10 patients (6.3%), but tracheostomy scores did not significantly differ between bleeders and nonbleeders.
Bilateral ND on its own is not a reliable predictor for elective tracheostomy. Furthermore, given the significant heterogeneity of currently available scoring systems, they prove inadequate for decision making and predictive modeling of tracheostomy placement.
4 Laryngoscope, 130:E580-E586, 2020.
评估头颈部鳞状细胞癌患者肿瘤切除和双侧颈部清扫(ND)后行选择性气管切开术的合理性,并探讨气管切开评分系统在术后气道管理规划中的应用是否可靠。
回顾性队列研究。
我们回顾性评估了 160 例头颈部鳞状细胞癌患者的气道管理情况。此外,我们对 1)卡梅隆(Cameron)、2)TRACHY 和 3)CASST 气管切开评分系统进行了应用和分析,并将这些评分系统应用于气管切开建议。
51.3%的患者行选择性气管切开术,尤其是 T3 至 T4 期肿瘤、游离皮瓣重建和同期手术的患者。同期手术患者中,行气管切开术的患者住院时间明显更长(27.8±30.0 天 vs. 13.3±6.6 天;P<0.001)。气管切开建议与双侧 ND 相符的病例分别占 28.6%(CASST)、60.0%(Cameron)和 75.0%(TRACHY)。按照相应标准,CASST、Cameron 和 TRACHY 评分系统分别建议行气管切开术的病例占比为 2.5%、76.9%和 84.4%。10 例(6.3%)患者出现出血并发症,最常见的并发症,但气管切开评分在出血组和非出血组之间无显著差异。
单纯双侧 ND 不是行选择性气管切开术的可靠预测指标。此外,鉴于目前可用评分系统的显著异质性,它们在气管切开术时机的决策和预测模型建立方面均存在不足。
4 Laryngoscope, 130:E580-E586, 2020.